Willem A. Hanekom

Researcher Next ID · RN-008947

Researcher · Medicine

Durban, South Africa

Not currently recruitingFunding unknown

Research interests

Medicine

Immunology and Microbiology

Tuberculosis Research and Epidemiology

Immunodeficiency and Autoimmune Disorders

Immune responses and vaccinations

Mycobacterium research and diagnosis

Infectious Diseases and Tuberculosis

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
Nature · 2021 · https://doi.org/10.1038/s41586-021-04387-1
Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma
Nature · 2021 · https://doi.org/10.1038/s41586-021-03471-w
Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination
New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1714021
A blood RNA signature for tuberculosis disease risk: a prospective cohort study
The Lancet · 2016 · https://doi.org/10.1016/s0140-6736(15)01316-1
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
The Lancet · 2013 · https://doi.org/10.1016/s0140-6736(13)60177-4

No projects listed.